0001213900-22-008949.txt : 20220223 0001213900-22-008949.hdr.sgml : 20220223 20220223161604 ACCESSION NUMBER: 0001213900-22-008949 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220222 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaplan Myron CENTRAL INDEX KEY: 0001672645 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34673 FILM NUMBER: 22663874 MAIL ADDRESS: STREET 1: C/O KLEINBERG, KAPLAN, WOLFF & COHEN, PC STREET 2: 551 FIFTH AVENUE, 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10176 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CorMedix Inc. CENTRAL INDEX KEY: 0001410098 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4200 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-9500 MAIL ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4200 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 4 1 doc4.xml PRIMARY DOCUMENT X0306 4 2022-02-22 false 0001410098 CorMedix Inc. CRMD 0001672645 Kaplan Myron C/O CORMEDIX INC. 300 CONNELL DRIVE 300 CONNELL DRIVE, SUITE 4200 BERKELEY HEIGHTS NJ 07922 true false false false Common Stock 155034.0000 D Stock Option (Right to Buy Common Stock) 4.0300 2022-02-22 4 A false 20000.0000 0.0000 A 2032-02-22 Common Stock 20000.0000 20000.0000 D Stock Option (Right to Buy Common Stock) 8.3200 2031-01-11 Common Stock 30000.0000 30000.0000 D Stock Option (Right to Buy Common Stock) 5.6300 2030-02-25 Common Stock 15000.0000 15000.0000 D Stock Option (Right to Buy Common Stock) 8.3000 2029-01-10 Common Stock 15000.0000 15000.0000 D Stock Option (Right to Buy Common Stock) 2.8500 2028-02-16 Common Stock 8000.0000 8000.0000 D Stock Option (Right to Buy Common Stock) 11.2000 2027-02-21 Common Stock 8000.0000 8000.0000 D Stock Option (Right to Buy Common Stock) 21.4000 2026-04-28 Common Stock 10000.0000 10000.0000 D These options were granted on 1/11/2021. These options are fully vested. These options were granted on 02/25/2020. These options are fully vested. These options were granted on 01/10/2019. These options are fully vested. These options were granted on 02/16/2018. These options are fully vested. These options were granted on 02/21/2017. These options are fully vested. These options were granted on 4/28/2016. These options are fully vested. These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. /s/ Myron Kaplan 2022-02-23